KYMR
85.83 USD
+0.24%
Today
-2.57%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
Kymera Therapeutics Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
7.13B
Avg Daily Volume
737.57K
52 Week High
103 USD
52 Week Low
19.445 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing KT-621, an oral STAT6 degrader in Phase 2b clinical trials for moderate to severe atopic dermatitis, asthma, COPD, EoE, CRSwNP, CSU, PN, BP, and others; KT-579, an oral IRF5 degrader in Phase 1 trials for autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, SSc, DM, and others; KT-485/SAR447971, IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis; and cyclin-dependent kinase 2 (CDK2) with broad oncology treatment potential, including in breast cancer and other solid tumors. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Top News
Autodesk
-2.91%
Amazon.com
+2.11%
Applied.Digital
+2.59%
Caterpillar
+0.37%
C4_Therapeutics
-11.03%
Carlyle_Group
-1.79%
CoreWeave
+10.49%
Fedex
-0.98%
GoodRx
+0.47%
Hormel
-1.61%
Kymera
-2.57%
Marvell-Technology
+6.68%
NorthropGr
-1.80%
ServiceNow
-7.84%
Occidental
+0.00%
SimplyGood
-11.54%
Staar_Surgical
+4.92%
ConstellationBrands
+4.05%
Tempus.AI
-2.73%
TeslaMotor
+1.03%
BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman
reuters.com
1d ago
Applied.Digital
+2.59%
Caterpillar
+0.37%
C4_Therapeutics
-11.03%
CoreWeave
+10.49%
Fedex
-0.98%
GoodRx
+0.47%
Hormel
-1.61%
Kymera
-2.57%
Marvell-Technology
+6.68%
Occidental
+0.00%
SimplyGood
-11.54%
Staar_Surgical
+4.92%
ConstellationBrands
+4.05%
Tempus.AI
-2.73%
TeslaMotor
+1.03%
BUZZ-U.S. STOCKS ON THE MOVE-Marvell Technology, Tempus AI, Energy Vault
reuters.com
1d ago
Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
tradingview.com
2d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
